semaglutide cancer cases and tirzepatide prescriptions for obesity in patients | JAMA Oncology posted on the topic GLP-1 Agonists May Alter Cancer

Tirzepatide is the first weight loss drug available by prescription that activates both of these receptors in your body

When combined with positive lifestyle changes, patients can expect to lose 21% of their body weight after 18 months of Mounjaro treatment, compared to 17% after 17 months on Wegovy

There were no signs of tubular necrosis, interstitial inflammation, or glomerular damage

A skin sensitivity test prior to administration is advised

This drops cortisol by 10-15% and soothes anxiety-driven hunger

Optimize Your Growth Hormone with Ipamorelin Schedule a consultation to discuss ipamorelin therapy, get baseline labs, and discover whether growth hormone optimization is right for your goals